We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VERSACLOZ clozapine 50 mg/mL oral suspension (TruPharma, USA)
Section 19A approved medicine
VERSACLOZ clozapine 50 mg/mL oral suspension (TruPharma, USA)
Section 19A approval holder
Douglas Pharmaceuticals Australia Pty Ltd ABN 61 612 164 824
Phone
03 7054 1243
Approved until
Status
Current
Medicines in short supply/unavailable
CLOPINE SUSPENSION clozapine 50 mg/mL oral liquid bottle - ARTG 142239
Indication(s)
Treatment with VERSACLOZ is indicated only in people with treatment-resistant schizophrenia, ie. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs.
Images
